tradmap

STAA Financials Staar Surgical Co

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 7.9% per year over the past 5 years.
  • Operating margin has contracted, at -38.3% in the latest year.

Financial health

  • The company is unprofitable; at its current free-cash-flow burn it has roughly 3.8 years of cash runway.
Revenue & net income
-$80M $121M $322M $0 2012 2015 2016 2018 2021 2021 2023 2026
RevenueNet income
Margins (gross / operating / net)
-38% 27% 93% 0% 2012 2015 2016 2018 2021 2021 2023 2026
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-32% -10% 12% 0% 2012 2015 2016 2018 2021 2021 2023 2026
ROEROA
Free cash flow (CFO − capex)
-$40M -$5M $30M $0 2012 2015 2016 2018 2021 2021 2023 2026
Free cash flow
Cash vs total debt
$0 $100M $200M 2012 2015 2016 2018 2021 2021 2023 2026
CashTotal debt
Cash flow: operating / investing / financing
-$156M -$41M $75M $0 2012 2015 2016 2018 2021 2021 2023 2026
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2026 $239M -$80M 76.2% -38.3% -23.4% -17.8% -$40M — $153M
2024 $314M -$20M 76.3% -4.0% -5.1% -4.0% -$8M — $144M
2023 $322M $21M 78.4% 8.7% 5.5% 4.4% -$4M — $183M
2022 $239M $40M 93.3% 18.3% 11.8% 9.5% $18M — $86M
2021 $230M $28M 77.5% 14.5% 10.5% 8.0% $30M — $200M
2021 — $28M — — — — — — —
2021 $163M $6M 72.4% 4.1% 3.0% 2.3% $13M — $152M
2020 $150M $14M 74.5% 7.9% 8.8% 6.8% $16M — $120M
2018 $124M $5M 73.8% 5.3% 3.8% 3.0% $11M — $104M
2017 $91M -$2M 70.9% -4.0% -5.0% -3.1% $2M — $19M
2016 $82M -$12M 70.8% -15.4% -32.0% -18.5% -$2M — $14M
2016 — -$7M — — -16.8% -10.4% -$4M — $13M
2015 — -$8M — — -22.6% -14.2% — — $13M
2014 — $398000 — — 1.0% 0.6% — — $23M
2012 — -$2M — — -5.6% -3.2% $946000 — $22M

Valuation over time

How the market has priced STAA against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 56.0 111.9 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 7.4 14.8 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is STAA growing its revenue and profit?

Over the past 5 years, Staar Surgical Co's revenue has grown 7.9% per year.

How much debt does STAA have?

As of FY2026, Staar Surgical Co reported — of total debt against $153M of cash.

What is STAA's profit margin?

In FY2026, gross margin was 76.2%, operating margin -38.3%, and net margin -33.6%.

What is STAA's P/E ratio?

Staar Surgical Co's P/E (TTM) is 2529.98 as of the 2026-11-05 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the STAA stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 68.5× as of Nov '26) can differ.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing.